Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-03-10 16:55:09
Reporting Period:
Filing Date:
Accepted Time:
2015-03-10 16:55:09
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289410 V Alexis Lukianov 7475 Lusk Blvd
San Diego CA 92121
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-06 18,750 $18.31 347,117 No 4 M Direct
Common Stock Disposition 2015-03-06 13,437 $44.92 333,680 No 4 F Direct
Common Stock Disposition 2015-03-09 5,313 $44.82 328,367 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2015-03-06 18,750 $0.00 18,750 $18.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-03 No 4 M Direct
  1. Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
  2. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
  3. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2014, which is intended to comply with Rule 10b5-1.
  4. Weighted average from 27 transactions with prices ranging from $44.560 to $45.050. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  5. The option, representing a right to purchase a total of 244,539 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period.